Maintenance Notice

Due to necessary scheduled maintenance, the JMIR Publications website will be unavailable from Wednesday, July 01, 2020 at 8:00 PM to 10:00 PM EST. We apologize in advance for any inconvenience this may cause you.

Who will be affected?

Accepted for/Published in: JMIR Rehabilitation and Assistive Technologies

Date Submitted: Dec 22, 2022
Open Peer Review Period: Dec 21, 2022 - Feb 15, 2023
Date Accepted: Apr 28, 2023
(closed for review but you can still tweet)

The final, peer-reviewed published version of this preprint can be found here:

Efficacy and Safety of Home-Based Cardiac Telemonitoring Rehabilitation in Patients After Transcatheter Aortic Valve Implantation: Single-Center Usability and Feasibility Study

Ashikaga K, Doi S, Yoneyama K, Suzuki N, Kuwata S, Koga M, Takeichi N, Watanabe S, Izumo M, Kida K, Akashi YJ

Efficacy and Safety of Home-Based Cardiac Telemonitoring Rehabilitation in Patients After Transcatheter Aortic Valve Implantation: Single-Center Usability and Feasibility Study

JMIR Rehabil Assist Technol 2023;10:e45247

DOI: 10.2196/45247

PMID: 37195764

PMCID: 10233439

Efficacy and safety of cardiac tele-monitoring rehabilitation in patients after transcatheter aortic valve implantation: a feasibility study

  • Kohei Ashikaga; 
  • Shunichi Doi; 
  • Kihei Yoneyama; 
  • Norio Suzuki; 
  • Shingo Kuwata; 
  • Masashi Koga; 
  • Naoya Takeichi; 
  • Satoshi Watanabe; 
  • Masaki Izumo; 
  • Keisuke Kida; 
  • Yoshihiro J Akashi

ABSTRACT

Background:

There are no reports regarding the efficacy of home-based cardiac tele-rehabilitation (hbTR) or its efficacy in comparison to standard cardiac rehabilitation (CR) in patients who have undergone transcatheter aortic valve implantation (TAVI).

Objective:

We aimed to investigate the efficacy of hbTR in patients who had undergone TAVI.

Methods:

This single-center, prospective study introduced hbTR to post-TAVI patients and the efficacy outcomes of the rehabilitation method were compared to a historical control cohort. Patients who underwent TAVI before hospital discharge were included. In the first two weeks after TAVI, patients underwent outpatient CR and were trained using tele-rehabilitation systems. Thereafter, patients underwent hbTR twice a week for 12 weeks. The control group, comprising six patients, performed standard outpatient CR at least once a week for 12–16 weeks. Efficacy was assessed using peak oxygen uptake (peak VO2) prior to and after CR.

Results:

Eleven patients were included in the hbTR group. All patients underwent 24 hbTR sessions during the 12-week training period, and no adverse events were observed. The mean age of the hbTR and control groups was 80.4±6.0 and 79.0±3.9 years, respectively. In the hbTR group, pre- and post-peak VO2 were 12.0±1.7 mL/min/kg and 14.3±2.7 mL/min/kg (P=.03), respectively. Peak VO2 changes in the hbTR and control groups were 2.4±1.4 mL/min/kg and 1.3±5.0 mL/min/kg (P=.64), respectively.

Conclusions:

Home-based cardiac tele-rehabilitation is a safe outpatient rehabilitation method. Its efficacy is not inferior to that of standard cardiac rehabilitation in patients who have undergone TAVI.


 Citation

Please cite as:

Ashikaga K, Doi S, Yoneyama K, Suzuki N, Kuwata S, Koga M, Takeichi N, Watanabe S, Izumo M, Kida K, Akashi YJ

Efficacy and Safety of Home-Based Cardiac Telemonitoring Rehabilitation in Patients After Transcatheter Aortic Valve Implantation: Single-Center Usability and Feasibility Study

JMIR Rehabil Assist Technol 2023;10:e45247

DOI: 10.2196/45247

PMID: 37195764

PMCID: 10233439

Download PDF


Request queued. Please wait while the file is being generated. It may take some time.

© The authors. All rights reserved. This is a privileged document currently under peer-review/community review (or an accepted/rejected manuscript). Authors have provided JMIR Publications with an exclusive license to publish this preprint on it's website for review and ahead-of-print citation purposes only. While the final peer-reviewed paper may be licensed under a cc-by license on publication, at this stage authors and publisher expressively prohibit redistribution of this draft paper other than for review purposes.